Effectiveness of Transcutaneous Electrical Nerve Stimulation and Interferential Current in Chronic Neck Pain
20 agosto 2026 aggiornato da: Busra Sirin, Beylikduzu State Hospital
Comparison of the Therapeutic Effectiveness of Transcutaneous Electrical Nerve Stimulation and Interferential Current in Patients With Chronic Neck Pain: A Prospective, Randomized, Double-Blind Study
The aim of this study was to determine and compare the efficacy of transcutaneous electrical nerve stimulation (TENS), interferential current (IFC), and sham therapy in patients with chronic neck pain.
A total of 57 patients diagnosed with chronic mechanical neck pain were included in the study. Patients were randomized into three groups. Each group received 10 sessions of physiotherapy over a two-week period: one group received conventional TENS, one group received IFC, and one group received sham therapy. Pain was assessed using the Visual Analog Scale (VAS), disability and functionality using the Copenhagen Neck Disability Index, quality of life using the SF-36, depression using the Beck Depression Inventory (BDI), and pain characteristics using the SF-McGill Pain Questionnaire.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Tipo di studio
Interventistico
Iscrizione (Effettivo)
57
Fase
- Non applicabile
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Sì
Descrizione
The inclusion criteria:
- having neck pain for more than six months,
- being between 18 and 60 years of age,
- having sufficient cognitive capacity to complete the study questionnaires,
- being functionally able to participate in an outpatient physical therapy program
- voluntarily agreeing to participate in the study.
The exclusion criteria:
- the presence of motor deficits due to neurological involvement;
- neurological conditions causing dizziness or balance loss;
- congenital pathology of the cervical spine;
- uncontrolled diabetes mellitus or hypertension; any contraindication to electrotherapy (such as pregnancy, severe arrhythmia, pacemaker, active infection, or skin lesions);
- having received physical therapy or injection treatment for the neck region within the past year;
- the presence of any connective tissue or rheumatologic disease (such as seronegative spondyloarthropathies or rheumatoid arthritis);
- the presence of a mass lesion in the cervical spine or neck region;
- a history of cervical spine fracture; and
- the presence of psychiatric or cognitive disorders.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: patients who received TENS for chronic neck pain
Transcutaneous electrical nerve stimulation (TENS) was applied to the cervical region using four electrodes.
Treatment was administered using a FİZYOMED FİZYOTENS-4000 device in conventional mode with a stimulation frequency of 40 Hz and a pulse duration of 100 μs.
Each session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
Transcutaneous electrical nerve stimulation (TENS) was applied to the cervical region using four electrodes.
Treatment was administered using a FİZYOMED FİZYOTENS-4000 device in conventional mode with a stimulation frequency of 40 Hz and a pulse duration of 100 μs.
Each session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
|
Sperimentale: patients who received IFC for chronic neck pain
Interferential current (IFC) therapy was applied to the cervical region using four electrodes and an ET 3000 combined electrotherapy device.
Treatment was administered with a carrier frequency of 4000 Hz, a stimulation frequency of 40 Hz, and an amplitude-modulated frequency (AMF) of 40 Hz using a 1/1 rectangular spectrum.
Each session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
Interferential current (IFC) therapy was applied to the cervical region using four electrodes and an ET 3000 combined electrotherapy device.
Treatment was administered with a carrier frequency of 4000 Hz, a stimulation frequency of 40 Hz, and an amplitude-modulated frequency (AMF) of 40 Hz using a 1/1 rectangular spectrum.
Each session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
|
Comparatore fittizio: Control
Sham electrotherapy was applied to the cervical region using four electrodes.
The electrotherapy device was turned on, but no electrical current was delivered.
Each sham treatment session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
Sham electrotherapy was applied to the cervical region using four electrodes.
The electrotherapy device was turned on, but no electrical current was delivered.
Each sham treatment session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Short-Form McGill Pain Questionnaire (SF-MPQ):
Lasso di tempo: Baseline, 3th weeks
|
The SF-MPQ, developed by Melzack in 1987 and validated in Turkish by Yakut et al., is widely used to assess pain.
It evaluates sensory, affective, and total pain dimensions, along with VAS and Present Pain Intensity (PPI).
The questionnaire consists of 15 descriptors (11 sensory and 4 affective), each scored from 0 (none) to 3 (severe), yielding sensory, affective, and total pain scores.
PPI is assessed using a 6-point Likert scale ranging from 0 (no pain) to 5 (unbearable pain)
|
Baseline, 3th weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Beck Depression Inventory (BDI):
Lasso di tempo: Baseline, 3th weeks
|
The BDI was developed by Beck et al., and its Turkish validity and reliability have been established.
The total score ranges from 0 to 63, with 0-21 indicating mild, 21-42 moderate, and 42-63 severe depression.
|
Baseline, 3th weeks
|
|
Copenhagen Neck Functional Disability Index (CNFDI): Copenhagen Neck Functional Disability Index (CNFDI):
Lasso di tempo: Baseline, 3th weeks
|
The CNFDI was developed by Jordan et al. in 1998, and its Turkish version was validated by Yapalı et al.
It consists of 15 items assessing pain intensity and its impact on daily activities, social interaction, and functional disability.
Total scores range from 0 to 30.
|
Baseline, 3th weeks
|
|
Short Form-36 (SF-36)
Lasso di tempo: Baseline, 3th weeks
|
The Turkish version of SF-36 was validated by Koçyiğit et al.
It consists of 36 items and 8 subscales assessing physical and mental health: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health.
|
Baseline, 3th weeks
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
1 gennaio 2015
Completamento primario (Effettivo)
1 maggio 2015
Completamento dello studio (Effettivo)
1 maggio 2015
Date di iscrizione allo studio
Primo inviato
15 agosto 2026
Primo inviato che soddisfa i criteri di controllo qualità
20 agosto 2026
Primo Inserito (Effettivo)
21 agosto 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
21 agosto 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
20 agosto 2026
Ultimo verificato
1 agosto 2026
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- bdh2000
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .